Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
500 participants
INTERVENTIONAL
2013-05-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Care Protocol in New Diagnosis of Type 2 Diabetes Mellitus and Associated Comorbidities in Primary Care
NCT03990857
Web-based Guided Self-Determination Intervention for Adults With Type 2 Diabetes in General Practice
NCT02575599
Impact of Self-care Education Program in Patients With Type 2 Diabetes in Primary Care in the Basque Country
NCT01642394
The Effects of Self-management Education Based on Theory of Planned Behavior on Patients With Type 2 Diabetes
NCT02594748
Impact of an Interprofessional Shared Decision-making and Goal-setting Decision Aid for Patients With Diabetes
NCT02379078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
First session main contents are on group operation rules (informed consent expression, confidentiality rules, ...), on reasons and expected results of this kind of self-care support programmes and on general aims and purposes. After explanations, patients are invited to answer a set of validated questionnaires on social, demographic and clinical data (including treatments and comorbidities), diabetes knowledge, self-care and self-assessment and quality of life. In this session body weight, arterial pressure and waist perimeter are also measured and registered. The most recent value (until three months before inclusion) of Haemoglobin A glycosylated will be collected from the lab information system.
The following sessions (from second to ninth) will approach several disease aspects like: what diabetes is, its diagnostic and treatment, acute and chronic complications, food and eating habits, physical exercise and healthy lifestyles, treatment (drugs and insulin) and disease self-control and self-care.
When intervention finishes, a follow-up period starts. At eighth and at 14th month from inclusion, participants will be summoned to provide again answers to questionnaires on knowledge, self-care, and quality of life. At both times, levels of Haemoglobin A glycosylated are also measured.
Patients assigned at control branch are summoned at inclusion to obtain complete baseline data, and also at month 8th and at month 14th. On these three occasions, these subjects answer the same questionnaires (including clinical, morbidity data and lab information) administered to intervention group patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetes expert patients programme
Diabetes expert patients programme: Participate in a scheduled and standardized expert patients programme course
Diabetes expert patients programme
Nine-weekly informative and educational sessions by a teaching patient who has experience on diabetes
No intervention
Don't participate in a scheduled and standardized expert patients programme course
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diabetes expert patients programme
Nine-weekly informative and educational sessions by a teaching patient who has experience on diabetes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Older than 18
Exclusion Criteria
* Psychosis
* Home nursing
* Mental disabled people
* Subjects unable to express themselves in Spanish or catalan languages
* Health professionals
* Subjects included simultaneously in other lifestyle counseling or health education programmes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catalan Institute of Health
OTHER_GOV
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carme Boix, RN
Role: PRINCIPAL_INVESTIGATOR
Catalan Institute of Health
Pere Roura-Poch, MD, MPH
Role: STUDY_DIRECTOR
Catalan Institute of Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catalan Health Institute, Barcelona District health Authority
Barcelona, Catalonia, Spain
Catalan Health Institute, Sud metropolitan District health Authority
L'Hospitalet de Llobregat, Catalonia, Spain
Catalan Health Institute, Catalonia midlands District health Authority
Sant Fruitós de Bages, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPPD-2012-ICS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.